Global Computational Drug Discovery Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
LPI (LP Information)' newest research report, the “Computational Drug Discovery Industry Forecast” looks at past sales and reviews total world Computational Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected Computational Drug Discovery sales for 2023 through 2029. With Computational Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Computational Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global Computational Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Computational Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Computational Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Computational Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Computational Drug Discovery.
The global Computational Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Computational Drug Discovery players cover AMRI, Charles River, Schr?dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Computational Drug Discovery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.
LPI (LP Information)' newest research report, the “Computational Drug Discovery Industry Forecast” looks at past sales and reviews total world Computational Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected Computational Drug Discovery sales for 2023 through 2029. With Computational Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Computational Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global Computational Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Computational Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Computational Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Computational Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Computational Drug Discovery.
The global Computational Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Computational Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Computational Drug Discovery players cover AMRI, Charles River, Schr?dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Computational Drug Discovery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Structure-based Drug Design (SBDD)
- Ligand-based Drug Design (LBDD)
- Sequence-based Approaches
- Oncological Disorders
- Neurological Disorders
- Immunological Disorders
- Infectious Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AMRI
- Charles River
- Schr?dinger
- Evotec
- Bayers
- GVK Biosciences
- AstraZeneca
- BioDuro
- BOC Sciences
- Aris Pharmaceuticals
- ChemDiv
- RTI International
- XRQTC
- Pharmaron
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Computational Drug Discovery Market Size 2018-2029
2.1.2 Computational Drug Discovery Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Computational Drug Discovery Segment by Type
2.2.1 Structure-based Drug Design (SBDD)
2.2.2 Ligand-based Drug Design (LBDD)
2.2.3 Sequence-based Approaches
2.3 Computational Drug Discovery Market Size by Type
2.3.1 Computational Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Computational Drug Discovery Market Size Market Share by Type (2018-2023)
2.4 Computational Drug Discovery Segment by Application
2.4.1 Oncological Disorders
2.4.2 Neurological Disorders
2.4.3 Immunological Disorders
2.4.4 Infectious Diseases
2.4.5 Others
2.5 Computational Drug Discovery Market Size by Application
2.5.1 Computational Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Computational Drug Discovery Market Size Market Share by Application (2018-2023)
3 COMPUTATIONAL DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 Computational Drug Discovery Market Size Market Share by Players
3.1.1 Global Computational Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Computational Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPUTATIONAL DRUG DISCOVERY BY REGIONS
4.1 Computational Drug Discovery Market Size by Regions (2018-2023)
4.2 Americas Computational Drug Discovery Market Size Growth (2018-2023)
4.3 APAC Computational Drug Discovery Market Size Growth (2018-2023)
4.4 Europe Computational Drug Discovery Market Size Growth (2018-2023)
4.5 Middle East & Africa Computational Drug Discovery Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Computational Drug Discovery Market Size by Country (2018-2023)
5.2 Americas Computational Drug Discovery Market Size by Type (2018-2023)
5.3 Americas Computational Drug Discovery Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Computational Drug Discovery Market Size by Region (2018-2023)
6.2 APAC Computational Drug Discovery Market Size by Type (2018-2023)
6.3 APAC Computational Drug Discovery Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Computational Drug Discovery by Country (2018-2023)
7.2 Europe Computational Drug Discovery Market Size by Type (2018-2023)
7.3 Europe Computational Drug Discovery Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Computational Drug Discovery by Region (2018-2023)
8.2 Middle East & Africa Computational Drug Discovery Market Size by Type (2018-2023)
8.3 Middle East & Africa Computational Drug Discovery Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPUTATIONAL DRUG DISCOVERY MARKET FORECAST
10.1 Global Computational Drug Discovery Forecast by Regions (2024-2029)
10.1.1 Global Computational Drug Discovery Forecast by Regions (2024-2029)
10.1.2 Americas Computational Drug Discovery Forecast
10.1.3 APAC Computational Drug Discovery Forecast
10.1.4 Europe Computational Drug Discovery Forecast
10.1.5 Middle East & Africa Computational Drug Discovery Forecast
10.2 Americas Computational Drug Discovery Forecast by Country (2024-2029)
10.2.1 United States Computational Drug Discovery Market Forecast
10.2.2 Canada Computational Drug Discovery Market Forecast
10.2.3 Mexico Computational Drug Discovery Market Forecast
10.2.4 Brazil Computational Drug Discovery Market Forecast
10.3 APAC Computational Drug Discovery Forecast by Region (2024-2029)
10.3.1 China Computational Drug Discovery Market Forecast
10.3.2 Japan Computational Drug Discovery Market Forecast
10.3.3 Korea Computational Drug Discovery Market Forecast
10.3.4 Southeast Asia Computational Drug Discovery Market Forecast
10.3.5 India Computational Drug Discovery Market Forecast
10.3.6 Australia Computational Drug Discovery Market Forecast
10.4 Europe Computational Drug Discovery Forecast by Country (2024-2029)
10.4.1 Germany Computational Drug Discovery Market Forecast
10.4.2 France Computational Drug Discovery Market Forecast
10.4.3 UK Computational Drug Discovery Market Forecast
10.4.4 Italy Computational Drug Discovery Market Forecast
10.4.5 Russia Computational Drug Discovery Market Forecast
10.5 Middle East & Africa Computational Drug Discovery Forecast by Region (2024-2029)
10.5.1 Egypt Computational Drug Discovery Market Forecast
10.5.2 South Africa Computational Drug Discovery Market Forecast
10.5.3 Israel Computational Drug Discovery Market Forecast
10.5.4 Turkey Computational Drug Discovery Market Forecast
10.5.5 GCC Countries Computational Drug Discovery Market Forecast
10.6 Global Computational Drug Discovery Forecast by Type (2024-2029)
10.7 Global Computational Drug Discovery Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AMRI
11.1.1 AMRI Company Information
11.1.2 AMRI Computational Drug Discovery Product Offered
11.1.3 AMRI Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AMRI Main Business Overview
11.1.5 AMRI Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Computational Drug Discovery Product Offered
11.2.3 Charles River Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 Schr?dinger
11.3.1 Schr?dinger Company Information
11.3.2 Schr?dinger Computational Drug Discovery Product Offered
11.3.3 Schr?dinger Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Schr?dinger Main Business Overview
11.3.5 Schr?dinger Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec Computational Drug Discovery Product Offered
11.4.3 Evotec Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Bayers
11.5.1 Bayers Company Information
11.5.2 Bayers Computational Drug Discovery Product Offered
11.5.3 Bayers Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bayers Main Business Overview
11.5.5 Bayers Latest Developments
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Information
11.6.2 GVK Biosciences Computational Drug Discovery Product Offered
11.6.3 GVK Biosciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GVK Biosciences Main Business Overview
11.6.5 GVK Biosciences Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Computational Drug Discovery Product Offered
11.7.3 AstraZeneca Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 BioDuro
11.8.1 BioDuro Company Information
11.8.2 BioDuro Computational Drug Discovery Product Offered
11.8.3 BioDuro Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 BioDuro Main Business Overview
11.8.5 BioDuro Latest Developments
11.9 BOC Sciences
11.9.1 BOC Sciences Company Information
11.9.2 BOC Sciences Computational Drug Discovery Product Offered
11.9.3 BOC Sciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BOC Sciences Main Business Overview
11.9.5 BOC Sciences Latest Developments
11.10 Aris Pharmaceuticals
11.10.1 Aris Pharmaceuticals Company Information
11.10.2 Aris Pharmaceuticals Computational Drug Discovery Product Offered
11.10.3 Aris Pharmaceuticals Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Aris Pharmaceuticals Main Business Overview
11.10.5 Aris Pharmaceuticals Latest Developments
11.11 ChemDiv
11.11.1 ChemDiv Company Information
11.11.2 ChemDiv Computational Drug Discovery Product Offered
11.11.3 ChemDiv Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 ChemDiv Main Business Overview
11.11.5 ChemDiv Latest Developments
11.12 RTI International
11.12.1 RTI International Company Information
11.12.2 RTI International Computational Drug Discovery Product Offered
11.12.3 RTI International Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 RTI International Main Business Overview
11.12.5 RTI International Latest Developments
11.13 XRQTC
11.13.1 XRQTC Company Information
11.13.2 XRQTC Computational Drug Discovery Product Offered
11.13.3 XRQTC Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 XRQTC Main Business Overview
11.13.5 XRQTC Latest Developments
11.14 Pharmaron
11.14.1 Pharmaron Company Information
11.14.2 Pharmaron Computational Drug Discovery Product Offered
11.14.3 Pharmaron Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pharmaron Main Business Overview
11.14.5 Pharmaron Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Computational Drug Discovery Market Size 2018-2029
2.1.2 Computational Drug Discovery Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Computational Drug Discovery Segment by Type
2.2.1 Structure-based Drug Design (SBDD)
2.2.2 Ligand-based Drug Design (LBDD)
2.2.3 Sequence-based Approaches
2.3 Computational Drug Discovery Market Size by Type
2.3.1 Computational Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Computational Drug Discovery Market Size Market Share by Type (2018-2023)
2.4 Computational Drug Discovery Segment by Application
2.4.1 Oncological Disorders
2.4.2 Neurological Disorders
2.4.3 Immunological Disorders
2.4.4 Infectious Diseases
2.4.5 Others
2.5 Computational Drug Discovery Market Size by Application
2.5.1 Computational Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Computational Drug Discovery Market Size Market Share by Application (2018-2023)
3 COMPUTATIONAL DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 Computational Drug Discovery Market Size Market Share by Players
3.1.1 Global Computational Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Computational Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPUTATIONAL DRUG DISCOVERY BY REGIONS
4.1 Computational Drug Discovery Market Size by Regions (2018-2023)
4.2 Americas Computational Drug Discovery Market Size Growth (2018-2023)
4.3 APAC Computational Drug Discovery Market Size Growth (2018-2023)
4.4 Europe Computational Drug Discovery Market Size Growth (2018-2023)
4.5 Middle East & Africa Computational Drug Discovery Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Computational Drug Discovery Market Size by Country (2018-2023)
5.2 Americas Computational Drug Discovery Market Size by Type (2018-2023)
5.3 Americas Computational Drug Discovery Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Computational Drug Discovery Market Size by Region (2018-2023)
6.2 APAC Computational Drug Discovery Market Size by Type (2018-2023)
6.3 APAC Computational Drug Discovery Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Computational Drug Discovery by Country (2018-2023)
7.2 Europe Computational Drug Discovery Market Size by Type (2018-2023)
7.3 Europe Computational Drug Discovery Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Computational Drug Discovery by Region (2018-2023)
8.2 Middle East & Africa Computational Drug Discovery Market Size by Type (2018-2023)
8.3 Middle East & Africa Computational Drug Discovery Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPUTATIONAL DRUG DISCOVERY MARKET FORECAST
10.1 Global Computational Drug Discovery Forecast by Regions (2024-2029)
10.1.1 Global Computational Drug Discovery Forecast by Regions (2024-2029)
10.1.2 Americas Computational Drug Discovery Forecast
10.1.3 APAC Computational Drug Discovery Forecast
10.1.4 Europe Computational Drug Discovery Forecast
10.1.5 Middle East & Africa Computational Drug Discovery Forecast
10.2 Americas Computational Drug Discovery Forecast by Country (2024-2029)
10.2.1 United States Computational Drug Discovery Market Forecast
10.2.2 Canada Computational Drug Discovery Market Forecast
10.2.3 Mexico Computational Drug Discovery Market Forecast
10.2.4 Brazil Computational Drug Discovery Market Forecast
10.3 APAC Computational Drug Discovery Forecast by Region (2024-2029)
10.3.1 China Computational Drug Discovery Market Forecast
10.3.2 Japan Computational Drug Discovery Market Forecast
10.3.3 Korea Computational Drug Discovery Market Forecast
10.3.4 Southeast Asia Computational Drug Discovery Market Forecast
10.3.5 India Computational Drug Discovery Market Forecast
10.3.6 Australia Computational Drug Discovery Market Forecast
10.4 Europe Computational Drug Discovery Forecast by Country (2024-2029)
10.4.1 Germany Computational Drug Discovery Market Forecast
10.4.2 France Computational Drug Discovery Market Forecast
10.4.3 UK Computational Drug Discovery Market Forecast
10.4.4 Italy Computational Drug Discovery Market Forecast
10.4.5 Russia Computational Drug Discovery Market Forecast
10.5 Middle East & Africa Computational Drug Discovery Forecast by Region (2024-2029)
10.5.1 Egypt Computational Drug Discovery Market Forecast
10.5.2 South Africa Computational Drug Discovery Market Forecast
10.5.3 Israel Computational Drug Discovery Market Forecast
10.5.4 Turkey Computational Drug Discovery Market Forecast
10.5.5 GCC Countries Computational Drug Discovery Market Forecast
10.6 Global Computational Drug Discovery Forecast by Type (2024-2029)
10.7 Global Computational Drug Discovery Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AMRI
11.1.1 AMRI Company Information
11.1.2 AMRI Computational Drug Discovery Product Offered
11.1.3 AMRI Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AMRI Main Business Overview
11.1.5 AMRI Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Computational Drug Discovery Product Offered
11.2.3 Charles River Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 Schr?dinger
11.3.1 Schr?dinger Company Information
11.3.2 Schr?dinger Computational Drug Discovery Product Offered
11.3.3 Schr?dinger Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Schr?dinger Main Business Overview
11.3.5 Schr?dinger Latest Developments
11.4 Evotec
11.4.1 Evotec Company Information
11.4.2 Evotec Computational Drug Discovery Product Offered
11.4.3 Evotec Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Evotec Main Business Overview
11.4.5 Evotec Latest Developments
11.5 Bayers
11.5.1 Bayers Company Information
11.5.2 Bayers Computational Drug Discovery Product Offered
11.5.3 Bayers Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bayers Main Business Overview
11.5.5 Bayers Latest Developments
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Information
11.6.2 GVK Biosciences Computational Drug Discovery Product Offered
11.6.3 GVK Biosciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GVK Biosciences Main Business Overview
11.6.5 GVK Biosciences Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Computational Drug Discovery Product Offered
11.7.3 AstraZeneca Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 BioDuro
11.8.1 BioDuro Company Information
11.8.2 BioDuro Computational Drug Discovery Product Offered
11.8.3 BioDuro Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 BioDuro Main Business Overview
11.8.5 BioDuro Latest Developments
11.9 BOC Sciences
11.9.1 BOC Sciences Company Information
11.9.2 BOC Sciences Computational Drug Discovery Product Offered
11.9.3 BOC Sciences Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BOC Sciences Main Business Overview
11.9.5 BOC Sciences Latest Developments
11.10 Aris Pharmaceuticals
11.10.1 Aris Pharmaceuticals Company Information
11.10.2 Aris Pharmaceuticals Computational Drug Discovery Product Offered
11.10.3 Aris Pharmaceuticals Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Aris Pharmaceuticals Main Business Overview
11.10.5 Aris Pharmaceuticals Latest Developments
11.11 ChemDiv
11.11.1 ChemDiv Company Information
11.11.2 ChemDiv Computational Drug Discovery Product Offered
11.11.3 ChemDiv Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 ChemDiv Main Business Overview
11.11.5 ChemDiv Latest Developments
11.12 RTI International
11.12.1 RTI International Company Information
11.12.2 RTI International Computational Drug Discovery Product Offered
11.12.3 RTI International Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 RTI International Main Business Overview
11.12.5 RTI International Latest Developments
11.13 XRQTC
11.13.1 XRQTC Company Information
11.13.2 XRQTC Computational Drug Discovery Product Offered
11.13.3 XRQTC Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 XRQTC Main Business Overview
11.13.5 XRQTC Latest Developments
11.14 Pharmaron
11.14.1 Pharmaron Company Information
11.14.2 Pharmaron Computational Drug Discovery Product Offered
11.14.3 Pharmaron Computational Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pharmaron Main Business Overview
11.14.5 Pharmaron Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Computational Drug Discovery Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Structure-based Drug Design (SBDD)
Table 3. Major Players of Ligand-based Drug Design (LBDD)
Table 4. Major Players of Sequence-based Approaches
Table 5. Computational Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 8. Computational Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 11. Global Computational Drug Discovery Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Computational Drug Discovery Revenue Market Share by Player (2018-2023)
Table 13. Computational Drug Discovery Key Players Head office and Products Offered
Table 14. Computational Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Computational Drug Discovery Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Computational Drug Discovery Market Size Market Share by Regions (2018-2023)
Table 19. Global Computational Drug Discovery Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Computational Drug Discovery Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Computational Drug Discovery Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Computational Drug Discovery Market Size Market Share by Country (2018-2023)
Table 23. Americas Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 25. Americas Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 27. APAC Computational Drug Discovery Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Table 29. APAC Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 31. APAC Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 33. Europe Computational Drug Discovery Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Computational Drug Discovery Market Size Market Share by Country (2018-2023)
Table 35. Europe Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 37. Europe Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Computational Drug Discovery Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Computational Drug Discovery
Table 46. Key Market Challenges & Risks of Computational Drug Discovery
Table 47. Key Industry Trends of Computational Drug Discovery
Table 48. Global Computational Drug Discovery Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Computational Drug Discovery Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Computational Drug Discovery Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Computational Drug Discovery Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. AMRI Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 53. AMRI Computational Drug Discovery Product Offered
Table 54. AMRI Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. AMRI Main Business
Table 56. AMRI Latest Developments
Table 57. Charles River Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 58. Charles River Computational Drug Discovery Product Offered
Table 59. Charles River Main Business
Table 60. Charles River Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Charles River Latest Developments
Table 62. Schr?dinger Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 63. Schr?dinger Computational Drug Discovery Product Offered
Table 64. Schr?dinger Main Business
Table 65. Schr?dinger Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Schr?dinger Latest Developments
Table 67. Evotec Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 68. Evotec Computational Drug Discovery Product Offered
Table 69. Evotec Main Business
Table 70. Evotec Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Evotec Latest Developments
Table 72. Bayers Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 73. Bayers Computational Drug Discovery Product Offered
Table 74. Bayers Main Business
Table 75. Bayers Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bayers Latest Developments
Table 77. GVK Biosciences Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 78. GVK Biosciences Computational Drug Discovery Product Offered
Table 79. GVK Biosciences Main Business
Table 80. GVK Biosciences Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GVK Biosciences Latest Developments
Table 82. AstraZeneca Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 83. AstraZeneca Computational Drug Discovery Product Offered
Table 84. AstraZeneca Main Business
Table 85. AstraZeneca Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AstraZeneca Latest Developments
Table 87. BioDuro Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 88. BioDuro Computational Drug Discovery Product Offered
Table 89. BioDuro Main Business
Table 90. BioDuro Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. BioDuro Latest Developments
Table 92. BOC Sciences Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 93. BOC Sciences Computational Drug Discovery Product Offered
Table 94. BOC Sciences Main Business
Table 95. BOC Sciences Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. BOC Sciences Latest Developments
Table 97. Aris Pharmaceuticals Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 98. Aris Pharmaceuticals Computational Drug Discovery Product Offered
Table 99. Aris Pharmaceuticals Main Business
Table 100. Aris Pharmaceuticals Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Aris Pharmaceuticals Latest Developments
Table 102. ChemDiv Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 103. ChemDiv Computational Drug Discovery Product Offered
Table 104. ChemDiv Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. ChemDiv Main Business
Table 106. ChemDiv Latest Developments
Table 107. RTI International Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 108. RTI International Computational Drug Discovery Product Offered
Table 109. RTI International Main Business
Table 110. RTI International Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. RTI International Latest Developments
Table 112. XRQTC Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 113. XRQTC Computational Drug Discovery Product Offered
Table 114. XRQTC Main Business
Table 115. XRQTC Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. XRQTC Latest Developments
Table 117. Pharmaron Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 118. Pharmaron Computational Drug Discovery Product Offered
Table 119. Pharmaron Main Business
Table 120. Pharmaron Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Pharmaron Latest Developments
Table 1. Computational Drug Discovery Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Structure-based Drug Design (SBDD)
Table 3. Major Players of Ligand-based Drug Design (LBDD)
Table 4. Major Players of Sequence-based Approaches
Table 5. Computational Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 8. Computational Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 11. Global Computational Drug Discovery Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Computational Drug Discovery Revenue Market Share by Player (2018-2023)
Table 13. Computational Drug Discovery Key Players Head office and Products Offered
Table 14. Computational Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Computational Drug Discovery Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Computational Drug Discovery Market Size Market Share by Regions (2018-2023)
Table 19. Global Computational Drug Discovery Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Computational Drug Discovery Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Computational Drug Discovery Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Computational Drug Discovery Market Size Market Share by Country (2018-2023)
Table 23. Americas Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 25. Americas Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 27. APAC Computational Drug Discovery Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Table 29. APAC Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 31. APAC Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 33. Europe Computational Drug Discovery Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Computational Drug Discovery Market Size Market Share by Country (2018-2023)
Table 35. Europe Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 37. Europe Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Computational Drug Discovery Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Computational Drug Discovery Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Computational Drug Discovery Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Computational Drug Discovery
Table 46. Key Market Challenges & Risks of Computational Drug Discovery
Table 47. Key Industry Trends of Computational Drug Discovery
Table 48. Global Computational Drug Discovery Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Computational Drug Discovery Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Computational Drug Discovery Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Computational Drug Discovery Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. AMRI Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 53. AMRI Computational Drug Discovery Product Offered
Table 54. AMRI Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. AMRI Main Business
Table 56. AMRI Latest Developments
Table 57. Charles River Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 58. Charles River Computational Drug Discovery Product Offered
Table 59. Charles River Main Business
Table 60. Charles River Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Charles River Latest Developments
Table 62. Schr?dinger Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 63. Schr?dinger Computational Drug Discovery Product Offered
Table 64. Schr?dinger Main Business
Table 65. Schr?dinger Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Schr?dinger Latest Developments
Table 67. Evotec Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 68. Evotec Computational Drug Discovery Product Offered
Table 69. Evotec Main Business
Table 70. Evotec Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Evotec Latest Developments
Table 72. Bayers Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 73. Bayers Computational Drug Discovery Product Offered
Table 74. Bayers Main Business
Table 75. Bayers Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bayers Latest Developments
Table 77. GVK Biosciences Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 78. GVK Biosciences Computational Drug Discovery Product Offered
Table 79. GVK Biosciences Main Business
Table 80. GVK Biosciences Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GVK Biosciences Latest Developments
Table 82. AstraZeneca Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 83. AstraZeneca Computational Drug Discovery Product Offered
Table 84. AstraZeneca Main Business
Table 85. AstraZeneca Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. AstraZeneca Latest Developments
Table 87. BioDuro Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 88. BioDuro Computational Drug Discovery Product Offered
Table 89. BioDuro Main Business
Table 90. BioDuro Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. BioDuro Latest Developments
Table 92. BOC Sciences Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 93. BOC Sciences Computational Drug Discovery Product Offered
Table 94. BOC Sciences Main Business
Table 95. BOC Sciences Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. BOC Sciences Latest Developments
Table 97. Aris Pharmaceuticals Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 98. Aris Pharmaceuticals Computational Drug Discovery Product Offered
Table 99. Aris Pharmaceuticals Main Business
Table 100. Aris Pharmaceuticals Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Aris Pharmaceuticals Latest Developments
Table 102. ChemDiv Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 103. ChemDiv Computational Drug Discovery Product Offered
Table 104. ChemDiv Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. ChemDiv Main Business
Table 106. ChemDiv Latest Developments
Table 107. RTI International Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 108. RTI International Computational Drug Discovery Product Offered
Table 109. RTI International Main Business
Table 110. RTI International Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. RTI International Latest Developments
Table 112. XRQTC Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 113. XRQTC Computational Drug Discovery Product Offered
Table 114. XRQTC Main Business
Table 115. XRQTC Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. XRQTC Latest Developments
Table 117. Pharmaron Details, Company Type, Computational Drug Discovery Area Served and Its Competitors
Table 118. Pharmaron Computational Drug Discovery Product Offered
Table 119. Pharmaron Main Business
Table 120. Pharmaron Computational Drug Discovery Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Pharmaron Latest Developments
LIST OF FIGURES
Figure 1. Computational Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Computational Drug Discovery Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Computational Drug Discovery Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Computational Drug Discovery Sales Market Share by Country/Region (2022)
Figure 8. Computational Drug Discovery Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Computational Drug Discovery Market Size Market Share by Type in 2022
Figure 10. Computational Drug Discovery in Oncological Disorders
Figure 11. Global Computational Drug Discovery Market: Oncological Disorders (2018-2023) & ($ Millions)
Figure 12. Computational Drug Discovery in Neurological Disorders
Figure 13. Global Computational Drug Discovery Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 14. Computational Drug Discovery in Immunological Disorders
Figure 15. Global Computational Drug Discovery Market: Immunological Disorders (2018-2023) & ($ Millions)
Figure 16. Computational Drug Discovery in Infectious Diseases
Figure 17. Global Computational Drug Discovery Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 18. Computational Drug Discovery in Others
Figure 19. Global Computational Drug Discovery Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Computational Drug Discovery Market Size Market Share by Application in 2022
Figure 21. Global Computational Drug Discovery Revenue Market Share by Player in 2022
Figure 22. Global Computational Drug Discovery Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 24. APAC Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 25. Europe Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 27. Americas Computational Drug Discovery Value Market Share by Country in 2022
Figure 28. United States Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Computational Drug Discovery Market Size Market Share by Region in 2022
Figure 33. APAC Computational Drug Discovery Market Size Market Share by Type in 2022
Figure 34. APAC Computational Drug Discovery Market Size Market Share by Application in 2022
Figure 35. China Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Computational Drug Discovery Market Size Market Share by Country in 2022
Figure 42. Europe Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Figure 43. Europe Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Figure 44. Germany Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 58. APAC Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 59. Europe Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 61. United States Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 62. Canada Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 65. China Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 66. Japan Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 67. Korea Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 69. India Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 70. Australia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 71. Germany Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 72. France Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 73. UK Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 74. Italy Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 75. Russia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 76. Spain Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 79. Israel Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 82. Global Computational Drug Discovery Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Computational Drug Discovery Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Computational Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Computational Drug Discovery Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Computational Drug Discovery Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Computational Drug Discovery Sales Market Share by Country/Region (2022)
Figure 8. Computational Drug Discovery Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Computational Drug Discovery Market Size Market Share by Type in 2022
Figure 10. Computational Drug Discovery in Oncological Disorders
Figure 11. Global Computational Drug Discovery Market: Oncological Disorders (2018-2023) & ($ Millions)
Figure 12. Computational Drug Discovery in Neurological Disorders
Figure 13. Global Computational Drug Discovery Market: Neurological Disorders (2018-2023) & ($ Millions)
Figure 14. Computational Drug Discovery in Immunological Disorders
Figure 15. Global Computational Drug Discovery Market: Immunological Disorders (2018-2023) & ($ Millions)
Figure 16. Computational Drug Discovery in Infectious Diseases
Figure 17. Global Computational Drug Discovery Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 18. Computational Drug Discovery in Others
Figure 19. Global Computational Drug Discovery Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Computational Drug Discovery Market Size Market Share by Application in 2022
Figure 21. Global Computational Drug Discovery Revenue Market Share by Player in 2022
Figure 22. Global Computational Drug Discovery Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 24. APAC Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 25. Europe Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Computational Drug Discovery Market Size 2018-2023 ($ Millions)
Figure 27. Americas Computational Drug Discovery Value Market Share by Country in 2022
Figure 28. United States Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Computational Drug Discovery Market Size Market Share by Region in 2022
Figure 33. APAC Computational Drug Discovery Market Size Market Share by Type in 2022
Figure 34. APAC Computational Drug Discovery Market Size Market Share by Application in 2022
Figure 35. China Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Computational Drug Discovery Market Size Market Share by Country in 2022
Figure 42. Europe Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Figure 43. Europe Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Figure 44. Germany Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Computational Drug Discovery Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Computational Drug Discovery Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Computational Drug Discovery Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Computational Drug Discovery Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 58. APAC Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 59. Europe Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 61. United States Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 62. Canada Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 65. China Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 66. Japan Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 67. Korea Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 69. India Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 70. Australia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 71. Germany Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 72. France Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 73. UK Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 74. Italy Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 75. Russia Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 76. Spain Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 79. Israel Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Computational Drug Discovery Market Size 2024-2029 ($ Millions)
Figure 82. Global Computational Drug Discovery Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Computational Drug Discovery Market Size Market Share Forecast by Application (2024-2029)
More Publications
Global Car Key Chips Market Growth 2025-2031
US$ 3,660.00
April 2025
83 pages
Global Flowchart and Diagramming Tools Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
105 pages
Global Nondispersive Infrared Sensors Market Growth 2025-2031
US$ 3,660.00
September 2025
178 pages
Global Electronic Alarm Clock Market Growth 2025-2031
US$ 3,660.00
March 2025
129 pages
Global Quantum Dot Market Growth 2025-2031
US$ 3,660.00
March 2025
102 pages
